Date: {{$ActivityAssignDate}}

Dear Dr. {{$doctorName}},

Subject: Post Marketing Surveillance Study of Lenvenib

Although every new product is marketed only after regulatory approval, it is important to know how it performs in day-to-day practice of individual medical practitioners. For this purpose, we have planned to conduct a retrospective study to assess the real-life performance of LENVENIB.

We invite you to participate in this study. All you need to do is to report on a standard form, your experience with LENVENIB in 5 consecutive patients (to avoid any bias) in whom you prescribe this product in the normal course of your practice. Thus, this is not an experimental study because the product will be prescribed and purchased as you and your patients normally do.

If you agree to participate, you will need to provide some basic relevant information of these {{$numberOfPatient}} patients. Let us assure you that the PMS form will not contain any information about the patients’ demography as to ensure confidentiality.

As you will be spending some extra time to keep, copy and verify these {{$numberOfPatient}} patients’ records, we offer to pay you a total professional fee of Rs. {{$contractAmount}}/- on receiving the details of {{$numberOfPatient}} patients.

We trust you and we are partners in promoting safe and effective drug therapy. In that spirit we hope you will consent to participate in this study. If you do, please sign and return the enclosed for our records.